Jin Medical International Ltd. (ZJYL) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 10.81M | 9.88M | 12.95M | 10.56M | 9.57M | 10.25M | 9.72M | 9.47M | 11.35M | 9.42M | 9.02M | 7.17M | 10.18M | 10.18M |
| Revenue Growth % | -16.53% | -6.4% | 35.29% | 2.96% | -1.59% | 8.3% | -14.32% | 0.55% | 25.75% | 31.33% | -11.4% | -29.59% | - | - |
| Cost of Goods Sold | 7.16M | 7.35M | 7.13M | 6.76M | 6.31M | 6.62M | 6.58M | 6.26M | 8.41M | 5.81M | 6.12M | 4.58M | 6.54M | 6.31M |
| COGS % of Revenue | 66.3% | 74.37% | 55.1% | 64.03% | 65.99% | 64.57% | 67.64% | 66.08% | 74.1% | 61.68% | 67.82% | 63.81% | 64.22% | 62.02% |
| Gross Profit | 3.64M | 2.53M | 5.81M | 3.8M | 3.25M | 3.63M | 3.15M | 3.21M | 2.94M | 3.61M | 2.9M | 2.59M | 3.64M | 3.87M |
| Gross Margin % | 33.7% | 25.63% | 44.9% | 35.97% | 34.01% | 35.43% | 32.36% | 33.92% | 25.9% | 38.32% | 32.18% | 36.19% | 35.78% | 37.98% |
| Gross Profit Growth % | -37.34% | -33.29% | 78.63% | 4.53% | 3.43% | 13.1% | 7.05% | -10.99% | 1.22% | 39.08% | -20.32% | -32.92% | - | - |
| Operating Expenses | 2.58M | 2.99M | 3.4M | 2.57M | 2.16M | 1.86M | 1.79M | 2.01M | 2.18M | 1.48M | 1.71M | 1.32M | 1.74M | 1.62M |
| OpEx % of Revenue | 23.87% | 30.23% | 26.29% | 24.33% | 22.56% | 18.15% | 18.43% | 21.18% | 19.22% | 15.68% | 18.99% | 18.4% | 17.11% | 15.9% |
| Selling, General & Admin | 1.68M | 2.2M | 2.47M | 1.9M | 1.25M | 1.13M | 952K | 1.22M | 971.08K | 1.19M | 971.69K | 910.44K | 1.08M | 898.81K |
| SG&A % of Revenue | 15.57% | 22.22% | 19.07% | 17.97% | 13.03% | 11.01% | 9.79% | 12.92% | 8.56% | 12.66% | 10.77% | 12.7% | 10.6% | 8.83% |
| Research & Development | 896.82K | 660.89K | 887.68K | 609.65K | 911.86K | 631.03K | 1M | 892.52K | 992.81K | 574.05K | 750.55K | 510.86K | 432.78K | 696.94K |
| R&D % of Revenue | 8.3% | 6.69% | 6.86% | 5.77% | 9.53% | 6.15% | 10.29% | 9.43% | 8.75% | 6.1% | 8.32% | 7.13% | 4.25% | 6.84% |
| Other Operating Expenses | 0 | 130.5K | 46.1K | 60.97K | 0 | 101.84K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 1.06M | -454.21K | 2.41M | 1.23M | 1.1M | 1.77M | 1.11M | 1.02M | 788.69K | 1.84M | 1.18M | 1.17M | 2.13M | 2.27M |
| Operating Margin % | 9.83% | -4.6% | 18.61% | 11.64% | 11.45% | 17.28% | 11.46% | 10.74% | 6.95% | 19.57% | 13.09% | 16.37% | 20.93% | 22.31% |
| Operating Income Growth % | -55.91% | -136.95% | 119.88% | -30.61% | -1.63% | 74.26% | 41.24% | -44.84% | -33.24% | 57.06% | -44.58% | -48.36% | - | - |
| EBITDA | 1.2M | -322.95K | 2.53M | 1.35M | 1.2M | 1.89M | 1.33M | 1.16M | 969.69K | 2.01M | 1.34M | 1.34M | 2.29M | 2.46M |
| EBITDA Margin % | 11.08% | -3.27% | 19.52% | 12.78% | 12.59% | 18.39% | 13.69% | 12.28% | 8.54% | 21.33% | 14.86% | 18.74% | 22.5% | 24.17% |
| EBITDA Growth % | -52.62% | -123.94% | 109.77% | -28.45% | -9.47% | 62.27% | 37.25% | -42.13% | -27.69% | 49.48% | -41.49% | -45.41% | - | - |
| D&A (Non-Cash Add-back) | 135.16K | 131.26K | 117.78K | 120.05K | 108.99K | 114.46K | 216.9K | 145.7K | 181K | 165.61K | 159.64K | 170.27K | 159.95K | 189.17K |
| EBIT | 1.06M | -454.21K | 2.41M | 1.23M | 1.25M | 1.77M | 1.11M | 1.02M | 788.69K | 1.84M | 1.18M | 1.17M | 2.13M | 2.27M |
| Net Interest Income | 487.54K | 603.07K | -215.06K | 681.59K | 0 | 94.57K | 112 | 69.8K | 24.78K | 34.28K | 57.9K | 54.51K | 0 | 0 |
| Interest Income | 487.54K | 603.07K | 0 | 681.59K | 0 | 94.57K | 112 | 69.8K | 24.78K | 34.28K | 57.9K | 54.51K | 11.44K | 34.29K |
| Interest Expense | 0 | 0 | 215.06K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 504.86K | 482.78K | -239.2K | 784.17K | 155.73K | 198.94K | 352.38K | 259.73K | -6.32K | 255.16K | -48.9K | 47.37K | -219.12K | -57.49K |
| Pretax Income | 1.57M | 28.56K | 2.17M | 2.01M | 1.25M | 1.97M | 1.47M | 1.28M | 782.37K | 2.1M | 1.13M | 1.22M | 1.91M | 2.21M |
| Pretax Margin % | 14.5% | 0.29% | 16.77% | 19.07% | 13.08% | 19.22% | 15.08% | 13.48% | 6.89% | 22.28% | 12.55% | 17.03% | 18.78% | 21.75% |
| Income Tax | 195.01K | 19.57K | 454.87K | 309.01K | 139.65K | 204.05K | -14.3K | 50.41K | -8.3K | 256.94K | 97.48K | 49.67K | 317.8K | 161.83K |
| Effective Tax Rate % | 12.44% | 68.5% | 20.96% | 15.35% | 11.16% | 10.36% | -0.97% | 3.95% | -1.06% | 12.25% | 8.61% | 4.07% | 16.62% | 7.31% |
| Net Income | 1.28M | -89.01K | 1.88M | 1.79M | 1.11M | 1.77M | 1.48M | 1.23M | 790.67K | 1.84M | 1.03M | 1.17M | 1.59M | 2.05M |
| Net Margin % | 11.85% | -0.9% | 14.54% | 16.99% | 11.62% | 17.23% | 15.23% | 12.95% | 6.97% | 19.55% | 11.47% | 16.33% | 15.66% | 20.16% |
| Net Income Growth % | -31.96% | -104.96% | 69.25% | 1.57% | -24.91% | 44.09% | 87.27% | -33.41% | -23.6% | 57.21% | -35.11% | -42.95% | - | - |
| Net Income (Continuing) | 1.37M | 9K | 1.72M | 1.7M | 1.11M | 1.77M | 1.48M | 1.23M | 790.67K | 1.84M | 1.03M | 1.17M | 1.59M | 2.05M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -66.25K | -156.23K | -262.72K | -89.25K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.16 | -0.01 | 0.24 | 0.23 | 0.14 | 0.26 | 0.22 | 0.18 | 0.04 | 0.09 | 0.05 | 0.06 | 0.08 | 0.10 |
| EPS Growth % | -33.33% | -105.26% | 69.01% | -12.31% | -35.45% | 44.44% | 450% | 95.65% | -23.08% | 53.33% | -35% | -42.31% | - | - |
| EPS (Basic) | 0.16 | -0.01 | 0.24 | 0.23 | 0.14 | 0.26 | 0.22 | 0.18 | 0.04 | 0.09 | 0.05 | 0.06 | 0.08 | 0.10 |
| Diluted Shares Outstanding | 7.83M | 7.83M | 7.83M | 7.82M | 7.8M | 6.76M | 6.75M | 6.75M | 20M | 20M | 20M | 20M | 20M | 20M |
| Basic Shares Outstanding | 7.83M | 7.84M | 7.83M | 7.82M | 7.8M | 6.76M | 6.75M | 6.75M | 20.01M | 20M | 20.01M | 20.01M | 20.01M | 20.01M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - |